Zinzino Group Revenue Increased 55%, Compared with the Previous Year

August 5, 2025
Press Release

The revenue in July for Zinzino‘s sales markets increased by 55 % and amounted to SEK 262.1 (169.1) million.

Faun Pharma’s external sales decreased and amounted to SEK 2.2 (10.3) million.

Overall, the Group increased by 64% and amounted to SEK 259.9 (158.8) million compared with the previous year.

Accumulated revenue for January – July 2025 increased by 57 % to SEK 1,780.1 (1,130.7) million.

Revenues were distributed as follows:

Regions, MSEK	25-Jul	24-Jul	Change	YTD 2025	YTD 2024	Change
The Nordics	26.1	23.4	12%	181.3	164.9	10%
Central Europe	76.1	44.1	73%	491.1	299.9	64%
East Europe	31.3	29.0	8%	217.8	220.6	-1%
South & West Europe	47.3	33.3	42%	309.3	193.6	60%
The Baltics	10.0	8.0	25%	66.8	55.5	20%
North America	47.2	16.7	183%	299.5	98.1	205%
Asia-Pacific	20.0	2.9	590%	169.0	28.2	499%
Africa	1.9	1.4	36%	12.1	8.3	46%
Zinzino	259.9	158.8	64%	1746.9	1069.1	63%
Faun Pharma	2.2	10.3	-79%	33.2	61.6	-46%
Zinzino Group	262.1	169.1	55%	1780.1	1130.7	57%

Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

About Zinzino

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world.

Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden, with additional offices in Europe, Asia, and Australia. For more information, please visit www.zinzino.com

Get more information, facts and figures about Zinzino, click here for the Zinzino overview.

Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.

Niculina et Alex Blonbou